5-(2,3-dihydrobenzo[b][1,4]dioxane-6-yl)-N-phenyl-3-(thiophen-2-yl)-4,5-dihydro-1H-pyrazole-1-carbothioamide

ID: ALA4286889

PubChem CID: 145990447

Max Phase: Preclinical

Molecular Formula: C22H19N3O2S2

Molecular Weight: 421.55

Molecule Type: Small molecule

Associated Items:

This compound is not in our inventory system

Names and Identifiers

Canonical SMILES:  S=C(Nc1ccccc1)N1N=C(c2cccs2)CC1c1ccc2c(c1)OCCO2

Standard InChI:  InChI=1S/C22H19N3O2S2/c28-22(23-16-5-2-1-3-6-16)25-18(14-17(24-25)21-7-4-12-29-21)15-8-9-19-20(13-15)27-11-10-26-19/h1-9,12-13,18H,10-11,14H2,(H,23,28)

Standard InChI Key:  DJWUWQKHGCJTLN-UHFFFAOYSA-N

Molfile:  

     RDKit          2D

 29 33  0  0  0  0  0  0  0  0999 V2000
    8.7034   -5.1711    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    7.8829   -5.1608    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    7.6171   -5.9370    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.2739   -6.4285    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.9453   -5.9534    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.1144   -4.4613    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.9362   -4.4672    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    8.7084   -3.7483    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
    6.9099   -6.3493    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.3480   -3.7613    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.1698   -3.7671    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.5844   -3.0560    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.1784   -2.3430    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.3579   -2.3411    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.9460   -3.0470    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.8514   -7.4444    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   11.1423   -7.0358    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.1423   -6.2145    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.8514   -5.8059    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   12.5605   -6.2145    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.5605   -7.0358    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.4332   -5.8059    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.7207   -6.2152    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.7200   -7.0358    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.4332   -7.4444    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.1610   -6.0215    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
    5.6158   -6.6322    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.0281   -7.3394    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.8280   -7.1657    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  2  0
  3  4  1  0
  4  5  1  0
  1  5  1  0
  6  7  1  0
  6  8  2  0
  1  6  1  0
  3  9  1  0
 10 11  1  0
 11 12  2  0
 12 13  1  0
 13 14  2  0
 14 15  1  0
 10 15  2  0
  7 10  1  0
 16 17  1  0
 17 18  1  0
 18 19  1  0
 19 20  1  0
 20 21  1  0
 16 21  1  0
 22 23  1  0
 23 24  2  0
 24 25  1  0
 17 25  2  0
 18 22  2  0
  5 23  1  0
  9 26  1  0
 26 27  1  0
 27 28  2  0
 28 29  1  0
 29  9  2  0
M  END

Alternative Forms

  1. Parent:

    ALA4286889

    ---

Associated Targets(Human)

BRAF Tclin Serine/threonine-protein kinase B-raf (11587 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
A-375 (9258 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
WM 266-4 (208 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
HT-29 (80576 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
HCT-116 (91556 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

Braf Serine/threonine-protein kinase B-raf (85 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 421.55Molecular Weight (Monoisotopic): 421.0919AlogP: 5.07#Rotatable Bonds: 3
Polar Surface Area: 46.09Molecular Species: NEUTRALHBA: 5HBD: 1
#RO5 Violations: 1HBA (Lipinski): 5HBD (Lipinski): 1#RO5 Violations (Lipinski): 1
CX Acidic pKa: 13.99CX Basic pKa: 0.31CX LogP: 5.12CX LogD: 5.12
Aromatic Rings: 3Heavy Atoms: 29QED Weighted: 0.60Np Likeness Score: -1.57

References

1. Li HL, Su MM, Xu YJ, Xu C, Yang YS, Zhu HL..  (2018)  Design and biological evaluation of novel triaryl pyrazoline derivatives with dioxane moiety for selective BRAFV600E inhibition.,  155  [PMID:29940463] [10.1016/j.ejmech.2018.06.043]

Source